T. Rowe Price Investment Management
USPH icon

T. Rowe Price Investment Management’s US Physical Therapy USPH Stock Holding History

T. Rowe Price Investment Management’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-773,008
Closed -$87.3M – 655
2024
Q1 		$87.3M Buy
773,008
+11,748
+2% +$1.17M 0.05% 309
2023
Q4 		$70.9M Buy
761,260
+14,708
+2% +$1.29M 0.05% 336
2023
Q3 		$68.5M Sell
746,552
-166,318
-18% -$17.9M 0.05% 315
2023
Q2 		$111M Buy
912,870
+38,300
+4% +$4.13M 0.08% 253
2023
Q1 		$85.6M Sell
874,570
-41,261
-5% -$3.94M 0.06% 285
2022
Q4 		$74.2M Buy
915,831
+3,618
+0.4% +$304K 0.06% 305
2022
Q3 		$69.3M Buy
+912,213
New +$87.7M 0.06% 299

Other funds holding USPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

T. Rowe Price Investment Management's USPH Position: Q2 2024 in Review

T. Rowe Price Investment Management sold out of US Physical Therapy (USPH) in Q2 2024, closing a stake of 773,008 shares — an estimated $87.3M sold.

T. Rowe Price Investment Management first reported a position in USPH in Q3 2022 and held it in 7 quarters. The position peaked at $111M in Q2 2023. 242 funds tracked by Wall St. Rank hold USPH as of Q2 2024.

  • T. Rowe Price Investment Management reported no remaining US Physical Therapy position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 773,008 US Physical Therapy shares in Q2 2024, an estimated $87.3M.
  • T. Rowe Price Investment Management first reported a position in US Physical Therapy in Q3 2022 and held it in 7 quarters.
  • T. Rowe Price Investment Management's US Physical Therapy position peaked at $111M in Q2 2023.
  • 242 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.